In silico Platform for designing genome-based
Personalized immunotherapy or Vaccine against Cancer

Predicted Immune Epitope Results

The result page of search shows exclusive peptide/epitopes generated due to mutation [Neoepitope], the tissue of origin [Tissue], position of peptide in protein [Position], number of mismatches counted by aligning mutated and normal protein sequence [Num Mismatch, percentage of cell lines with this peptide over total number of cell lines [Promiscuity %]. The immune information include CTL epitopes (Yes/No), MHC I binders, MHC II binders (both given as number of alleles) and B cell epitopes (Yes/No). For more information, please click HERE

NeoepitopesVVSASISDM        Click here to BLAST against human proteome
CTL Epitope
HLA I Alleles
(ProPred I)
HLA-A*0205, HLA-B*3501, HLA-B*51, HLA-B7, MHC-Db revised5
HLA I Alleles
HLA II Alleles
DRB1_0301, DRB1_0306, DRB1_0307, DRB1_0308, DRB1_0309, DRB1_0311, DRB1_0404, DRB1_0405, DRB1_0408, DRB1_0410, DRB1_0423, DRB1_0806, DRB1_0813, DRB1_1107, DRB1_1120, DRB1_1301, DRB1_1302, DRB1_1304, DRB1_1327, DRB1_132820

CANCERTOPE    |     Raghava's Group    |     IMTECH    |     CSIR    |     CRDD    |     GPSR Package